Editorial: Focusing on T-Cells for Novel Treatments of Systemic Lupus Erythematosus.

Ichinose, Kunihiro; Hedrich, Christian Michael; Moulton, Vaishali R; Mizui, Masayuki

Ichinose, Kunihiro; Hedrich, Christian Michael; Moulton, Vaishali R; Mizui, Masayuki.

Ichinose K; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Hedrich CM; Department of Women's and Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom.
Moulton VR; Division of Rheumatology and Clinical Immunology, Alder Hey Children's NHS Foundation Trust Hospital, Liverpool, United Kingdom.
Mizui M; Division of Rheumatology and Clinical Immunology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States.

Front Immunol ; 12: 744866, 2021.

Article in English | MEDLINE | ID: covidwho-1376704

Subject(s)

Cell- and Tissue-Based Therapy/methods; Lupus Erythematosus, Systemic/immunology; Lupus Erythematosus, Systemic/therapy; T-Lymphocytes/immunology; Humans

Keywords

Th17/Treg balance; immunometabolism; innate lymphocytes; lupus T-cells; post-transcriptional regulation

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: T-Lymphocytes / Cell- and Tissue-Based Therapy / Lupus Erythematosus, Systemic Limits: Humans Language: English Journal: Front Immunol Year: 2021 Document Type: Article Affiliation country: Fimmu.2021.744866

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google